ARACHIDONIC ACID Sodium Arachidonate
Catalog No. 101297
Arachidonic Acid (Sodium Arachidonate) is for use in routine platelet aggregation studies for the differential diagnosis of aspirin-like release defects and Storage Pool Disease.
Assess the Effect of Aspirin on Platelet Aggregation
Detect the Presence of Aspirin-like Release Defects
Evaluate the Inhibition of TX A2 Production
Confirm Patient Compliance when Aspirin Monotherapy or Dual Antiplatelet Therapy (DAPT) are Prescribed
Shelf Life of Two Years
Arachidonic Acid is a fatty acid present in the granules and membranes of human platelets.
It is liberated from phospholipids and, in the presence of the enzyme cyclo-oxygenase, incorporates oxygen to form the endoperoxide prostaglandin G2 (PGG2). PGG2 is then quickly transformed to prostaglandin H2 (PGH2) which in turn is converted to thromboxane A2 a potent inducer of platelet aggregation. Ingestion of aspirin or aspirin-containing compounds inhibits cyclo-oxygenase mediated oxygen consumption, thus precluding all subsequent events leading to platelet aggregation.
Net Contents: 3 x 0.5 mL
YOU MAY ALSO BE INTERESTED IN: